A Bootstrap Approach for Predicting Methoxyflurane Occupational Exposure in Paramedicine (2017)
© 2017 Background - Methoxyflurane was used as an anaesthetic agent from 1958 until it was withdrawn around 1974 after dose-related patient nephrotoxicity was identified. It is now available only for administration via the Medical Developments International Penthrox Inhaler device for analgesia. When administering methoxyflurane, ambulance officers will be exposed to some methoxyflurane vapour. A previous study has extrapolated data from anaesthetized patients to suggest that such occupational exposure is within safe limits. There is a need to explore the robustness of these thresholds. Approach - A model is created to investigate the range of possible regression lines from repeated bootstrap samples of the same patient data, and to describe the probability distribution of those regression lines. Findings - The model shows a wide range of possible extrapolations due to the limited patient data set and the extrapolation being conducted over 2 - 5 orders of magnitude of exposure. With the range of ambulance officer exposures reported elsewhere, 95.7% of these regressions fall within an identified safe limit, suggesting that one-off exposures of this nature are safe. This model does not account for repeated exposures over days or weeks as would be seen in occupational settings. Originality - Bootstrapping methods are applied to test the statistical robustness of extrapolation. Results indicate that ambulance crews could be safe if exposed between the limits currently in place.
CitationAllison SJ, Docherty PD, Pons D, Chase JG (2017). A Bootstrap Approach for Predicting Methoxyflurane Occupational Exposure in Paramedicine. IFAC-PapersOnLine. 50. 1. 6666-6671.
This citation is automatically generated and may be unreliable. Use as a guide only.
KeywordsIdentification and validation; Clinical validation; Healthcare management; Physiological models; Physiology; Parameter identification; Health and safety
ANZSRC Fields of Research32 - Biomedical and clinical sciences::3202 - Clinical sciences::320201 - Anaesthesiology
32 - Biomedical and clinical sciences::3214 - Pharmacology and pharmaceutical sciences::321407 - Toxicology (incl. clinical toxicology)
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320219 - Paramedicine
35 - Commerce, management, tourism and services::3505 - Human resources and industrial relations::350505 - Occupational and workplace health and safety
RightsAll rights reserved unless otherwise stated
Showing items related by title, author, creator and subject.
Little A; Wordsworth R; Malinen S (Emerald, 2019)© 2019, Emerald Publishing Limited. Purpose: Past research identifies many positive outcomes associated with workplace exercise initiatives. Realizing these outcomes is, however, dependent on securing sustained employee ...
Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats Gray VC; Hughes RN (ELSEVIER SCIENCE BV, 2015)© 2014 Elsevier B.V. In an effort to address the need to include both sexes in studies of effects of the SSRI fluoxetine, the NRI reboxetine and the SNRI venlafaxine on anxiety-related behavior and memory along with the ...
Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: Potential treatment to improve insulin-like growth factor-1 function Fan D; Alamri Y; Liu K; Harris P; Brimble M; Dalrymple-Alford J; Prickett T; Menzies O; Laurenson A; Anderson T; Guan J; MacAskill M (2018)© 2018 by the authors. Licensee MDPI, Basel, Switzerland. Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective ...